cysteine has been researched along with Acute Confusional Senile Dementia in 173 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 20 (11.56) | 18.2507 |
| 2000's | 59 (34.10) | 29.6817 |
| 2010's | 65 (37.57) | 24.3611 |
| 2020's | 29 (16.76) | 2.80 |
| Authors | Studies |
|---|---|
| Bellier, JP; Irie, K; Irie, Y; Kageyama, Y; Kume, T; Maki, T; Matsushima, Y; Tooyama, I; Yanagita, RC | 1 |
| Papanikolopoulou, K; Prifti, E; Samiotaki, M; Skoulakis, EMC; Stamatakis, G; Tsakiri, EN; Vourkou, E | 1 |
| Cho, EJ; Eom, JW; Kim, KR; Kim, YH; Lipton, SA; Nakamura, T; Oh, CK; Oh, SS | 1 |
| Annadurai, N; Das, V; Hajdúch, M; Malina, L; Malohlava, J | 1 |
| Bretonnière, Y; Girod, M; Guillaubez, JV; Lemoine, J; Pitrat, D | 1 |
| Lipton, SA | 1 |
| Bacchella, C; Casella, L; Dell'Acqua, S; Gentili, S; Monzani, E; Mozzi, SI; Tegoni, M | 1 |
| Belousova, AV; Chaprov, KD; Kim, GA; Kopchuk, DS; Krinochkin, AP; Minin, AS; Nikonov, IL; Nosova, EV; Santra, S; Shtaitz, YK; Slovesnova, NV; Starnovskaya, ES; Tsmokalyuk, AN; Ustyugov, AA; Valieva, MI; Zyryanov, GV | 1 |
| Dhushyandhun, ME; Elangovan, S; Gulia, KK; Jayasree, RS; Rekha, CR; Resmi, AN; Shenoy, SJ | 1 |
| Kannan, RR; Wilson Alphonse, CR | 1 |
| Ni, P; Pan, K; Zhao, B | 1 |
| Aoyama, K; Matsumura, N | 1 |
| Cao, B; Feng, WS; Hao, FX; Jiao, XM; Liang, XW; Zeng, MN; Zheng, XK | 1 |
| DiNicolantonio, JJ; McCarty, MF; O'Keefe, JH | 1 |
| Andrade, V; Cortés, N; Gonzalez, A; Maccioni, RB; Pastene, E; Pastor, G; Ramos-Escobar, N; Rojo, LE | 1 |
| Berg, EA; Fishman, JB | 1 |
| Rhoades, E; Wickramasinghe, SP | 1 |
| Afolayan, OO; Agie, JA; Fidelis, OP; Ogunlade, B | 1 |
| Deal, AK; Gibbs, D; Liao, L; Lipton, SA; Lopez, KM; Masliah, E; Nakamura, T; Oh, CK; Rissman, RA; Scott, HR; Spencer, B; Yates, JR; Zhang, X | 1 |
| Chen, Z; Cheng, X; Ding, T; Liu, J; Niu, Y; Tang, B; Tong, L; Yang, Y; Zhang, G | 1 |
| Chidambaram, H; Chinnathambi, S | 1 |
| Ai, L; Di, Y; Fei, X; He, R; Jiang, W; Lyu, J; Tong, Z; Yao, D; Yue, X; Zhang, J; Zhao, S | 1 |
| Clark, LR; Darst, BF; Engelman, CD; Franz, CE; Hogan, KJ; Huo, Z; Johnson, SC; Jonaitis, EM; Koscik, RL; Kremen, WS; Lu, Q; Lyons, MJ; Rana, B; Zhao, J | 1 |
| Belaidi, AA; Lei, P; Li, H; Tuo, QZ; Xu, S; Yan, HF; Zou, T | 1 |
| Guo, Z; Yoon, A; Zhen, J | 1 |
| Chen, H; Chen, J; Fu, G; Han, H; Li, X; Wang, F; Wu, W; Zhou, D; Zhou, J | 1 |
| Chang, CC; Chang, YT; Chiu, PY; Chuang, KS; Hsiao, IT; Hung, GU; Lin, KJ; Lin, WB; Lin, ZK; Ni, YC; Pai, MC; Tseng, FP | 1 |
| Gan, Y; Jiang, H; Li, H; Liu, M; Yao, S; Yin, G; Yin, P; Yu, T; Zhang, Y | 1 |
| Anand, BG; Brünnert, D; Goyal, P; Hanschmann, EM; Kar, K; Kateriya, S; Kaushik, V; Sharma, PK | 1 |
| Aso, Y; Ishibashi, M; Kimura, N; Matsubara, E | 1 |
| Kawaguchi, C; Kohara, S; Onaka, H; Ryo, M; Shimizu, M; Takahashi, W; Yoshii, F | 1 |
| Chen, H; Chen, J; Li, S; Liu, Q; Liu, S; Ni, J | 1 |
| Arancio, O; Argyrousi, EK; Nicholls, RE; Staniszewski, A | 1 |
| Al-Hilaly, YK; Baddeley, T; Harrington, CR; Pollack, SJ; Raulin, AC; Rickard, JE; Schellenberger, P; Serpell, LC; Simpson, M; Storey, JMD; Wischik, CM | 1 |
| Bano, S; Ibrahim, M; Jamil, F; Kanwal, S; Rasheed, MA | 1 |
| Akhtar, M; Hussain, S; Najmi, AK; Rahman, SO; Singh, RK | 1 |
| Brewer, GJ; Digman, MA; Dong, Y; Sameni, S | 1 |
| Ballatore, C; Brunden, KR; Crowe, A; James, MJ; Lee, VM; Smith, AB; Trojanowski, JQ | 1 |
| George, RC; Graves, DJ; Lew, J | 1 |
| Deth, R; Hodgson, N; Li, S; Muratore, C; Trivedi, M | 1 |
| Hayashi, S; Ikeda, C; Nagao, S; Oshima, E; Sato, S; Shindo, A; Terada, S; Uchitomi, Y; Yokota, O | 1 |
| Mahalakshmi, R; Maurya, SR | 1 |
| Chen, YJ; Hou, SJ; Huang, FL; Lin, CH; Shiao, YJ; Shie, FS; Tsay, HJ; Yang, CN | 1 |
| Gerdes, BC; Kaja, S; Koulen, P; McCalley, AE; Naumchuk, Y; Payne, AJ | 1 |
| Ahmed, N; Asif, AR; Khan, R; Oellerich, M; Zahid, S | 1 |
| Hayashi, S; Hayashibara, C; Ikeda, C; Nagao, S; Oshima, E; Sato, S; Terada, S; Uchitomi, Y; Yokota, O | 1 |
| Honda, H; Ikeda, C; Nagao, S; Oshima, E; Sato, S; Terada, S; Uchitomi, Y; Yokota, O | 1 |
| Arima, K; Imabayashi, E; Ito, K; Matsuda, H; Nakata, Y; Omachi, Y; Sato, N; Shimano, Y | 1 |
| Brewer, GJ; Ghosh, D | 1 |
| Anderson, GM; Baguley, TD; Brouillette, J; Chatterjee, M; Cuny, GD; Ellman, JA; Foscue, E; Ghosh, D; Glicksman, MA; Greengard, P; Gresack, J; Kanyo, J; Kurup, P; Lam, TT; Lombroso, PJ; Nairn, AC; Ononenyi, C; Seyb, K; Tautz, L; Xu, J; Zhang, Y | 1 |
| Lee, TH; Yang, HY | 1 |
| Evans, AR; Gu, L; Robinson, RA | 1 |
| Araki, T; Doi, H; Inamizu, S; Kira, J; Murai, H; Saito, BY | 1 |
| Chaves, S; Keri, RS; Quintanova, C; Santos, MA | 1 |
| Cardoso, SM; Chaves, S; Keri, RS; Quintanova, C; Santos, MA; Silva, DF | 1 |
| Julius, A; Langosch, D; Steiner, H; Winkler, E | 1 |
| Denzer, I; Friedland, K; Münch, G; Pischetsrieder, M | 1 |
| Liu, W; Luo, Y; Tian, Y; Yu, Y; Zhang, L | 1 |
| Almeida, OF; Ihara, Y; Kimura, T; Kondoh, Y; Koyama, H; Maeda, S; Miyasaka, T; Osada, H; Saito, A; Soeda, Y; Sugimoto, H; Sumioka, A; Suzuki, M; Takashima, A; Yoshiike, Y; Yoshikawa, M | 1 |
| Gu, L; Robinson, RA | 2 |
| Do, SI; Lee, KY; Ryu, IH | 1 |
| Allan, SM; Bagnall, J; Baldwin, AG; Booth, SJ; Brough, D; Daniels, MJ; Eder, C; Fasolino, V; Fischer, N; Freeman, S; Galea, J; Harte, MK; Jackson, J; Koziel, V; Latta, C; Lawrence, CB; Paszek, P; Pillot, T; Rivers-Auty, J; Schilling, T; Spencer, NG; Watremez, W; White, CS; Wong, R; Yu, S | 1 |
| Hayashi, S; Ishihara, T; Miki, T; Oshima, E; Sato, S; Terada, S; Yamada, N; Yokota, O | 1 |
| He, Z; Huang, Z; Liu, S; Liu, X; Wang, Z; Wu, Y; Zhou, J | 1 |
| Akiyama, H; Hashimoto, H; Higashiyama, S; Inoue, K; Kai, T; Kataoka, K; Kawabe, J; Kiriike, N; Shimada, A; Shiomi, S | 1 |
| Fujii, K; Furukawa, Y; Kobayashi, S; Morii, H; Saito, T; Shirasaka, T; Tateno, M; Utsumi, K; Yasumura, S | 1 |
| Beal, MF; Chen, HL; Gibson, GE; Karuppagounder, SS; Pinto, JT; Xu, H | 1 |
| Matsuda, H; Mizumura, S; Waragai, M; Yamada, T | 1 |
| Dubois, B; Fertil, B; Giron, A; Habert, MO; Horn, JF; Lotterie, JA; Mahieux, F; Onen, F; Portet, F; Puel, M; Sarazin, M; Touchon, J; Verny, M; Zanca, M | 1 |
| Kaminaka, K; Matsuda, J; Nozaki, C | 1 |
| Cappai, R; Coleman, BM; Han, S; Hatters, DM; Hill, AF; Nisbet, RM | 1 |
| Cho, DH; Cieplak, P; Fang, J; Godzik, A; Gu, Z; Lipton, SA; Nakamura, T | 1 |
| Gómez-Río, M; Górriz, JM; Illan, IA; López, M; Puntonet, CG; Ramírez, J; Salas-Gonzalez, D; Segovia, F | 1 |
| Alvarez, I; Chaves, R; Górriz, JM; López, M; Ramírez, J; Salas-Gonzalez, D; Segovia, F | 1 |
| Chen, J; Fan, JB; Liang, Y; Mo, ZY; Zhu, HL; Zhu, YZ | 1 |
| Alvarez, I; Chaves, R; Górriz, JM; López, M; Padilla, P; Ramírez, J; Salas-Gonzalez, D; Segovia, F | 1 |
| Bruno, G; Confaloni, A; Crestini, A; Gasparini, M; Lenzi, GL; Malvezzi-Campeggi, L; Piacentini, E; Piscopo, P; Talarico, G | 1 |
| Ho, MW; Lin, CY; Mong, MC; Tsai, SJ; Yin, MC | 1 |
| Bossy, B; Bossy-Wetzel, E; Chen, J; Klinglmayr, E; Knott, AB; Lütz-Meindl, U; Masliah, E; Petrilli, A; Schwarzenbacher, R | 1 |
| Cuberas-Borros, G; Roca, I | 1 |
| Hirota, M; Morisawa, H; Nakamura, M; Nishigaki, R; Toda, T; Yoshimi, Y | 1 |
| Declerck, J; Herholz, K; Kornhuber, J; Kuwert, T; Markiewicz, PJ; Matthews, JC; Merhof, D; Platsch, G; Weih, M | 1 |
| Gong, QH; Huang, H; Liu, XH; Pan, LL; Wang, Q; Zhu, YZ | 1 |
| Chauhan, NB; Lahiri, DK; Ray, B | 2 |
| Albin, R; Banerjee, R; Garg, SK; Vitvitsky, V | 1 |
| Ciaccio, C; Coletta, M; Grasso, G; Pappalardo, G; Pietropaolo, A; Rizzarelli, E; Spoto, G; Tundo, GR | 1 |
| Ahmad, A; Ahmed, ME; Ashafaq, M; El-Agnaf, OM; Islam, F; Javed, H; Khan, A; Khan, MM; Khuwaja, G; Raza, SS; Safhi, MM; Siddiqui, MS; Tabassum, R; Vaibhav, K | 1 |
| Chiu, CP; Tsai, SJ; Yang, HT; Yin, MC | 1 |
| Aw, TY; Circu, ML; Feng, J; Rodriguez, C; Zhang, C | 1 |
| Cao, G; Holland, EA; Lipton, SA; McKercher, SR; Nakamura, T; Qu, J | 1 |
| Guo, Z; Ngo, S | 1 |
| Capone, R; Jang, H; Kagan, BL; Kotler, SA; Lal, R; Nussinov, R | 1 |
| Berndt, P; Busch, K; Czech, C; Hampel, H; Kastler, J; Most, V; Schmitz, O; Senn, H; Wiemer, J | 1 |
| Galván, I; Ghanem, G; Møller, AP | 1 |
| Cotella, D; Hernandez-Enriquez, B; Leveille, J; Li, R; Link, CD; Oddo, S; Pan, Z; Sesti, F; Wu, X | 1 |
| Lipton, SA; Nakamura, T | 1 |
| Black, SE; MacIntosh, BJ; Makedonov, I | 1 |
| Battle, K; Feng, J; Hollins, BC; Njoroge, SK; Soper, SA; Wang, S; Zhang, C | 1 |
| Blacher, J; Caillat-Vigneron, N; Farid, K; Petras, S; Plou, C; Volpe-Gillot, L | 1 |
| Andreyeva, A; Gottmann, K; Horn, AH; Korth, C; Müller-Schiffmann, A; Sticht, H | 1 |
| Akoury, E; Biernat, J; Gajda, M; Mandelkow, E; Pickhardt, M; Zweckstetter, M | 1 |
| Buz'Zard, AR; Lau, BH; Peng, Q | 1 |
| Brenot-Rossi, I; Gastaut, JL; Hassan-Sebbag, N; Michel, BF; Pasquier, J; Sauvan, R | 1 |
| Asada, T; Imabayashi, E; Kanetaka, H; Katoh, A; Matsuda, H; Nakano, S; Ohnishi, T; Tanaka, F | 1 |
| Barghorn, S; Mandelkow, E | 1 |
| Barber, J; Davies, G; Hill, D; Hudson, P; Lloyd, A; McCaddon, A; Regland, B | 1 |
| Darcourt, J; Girtler, N; Koulibaly, PM; Migneco, O; Nobili, F; Robert, PH; Rodriguez, G; Vitali, P | 1 |
| Hong, CJ; Liu, HC; Liu, TY; Tsai, SJ; Wang, KY | 1 |
| Blom, HJ; Bosma, H; Bosmans, E; De Bruijn, C; de Vente, J; Delanghe, J; Lütjohann, D; Maes, M; Rieckmann, P; Steinbusch, HW; Teunissen, CE; van Boxtel, MP; Verbeek, MM; Verhey, F; von Bergmann, K; Vreeling, F; Wauters, A | 1 |
| Buxbaum, JD; Causevic, M; Davis, KL; Haroutunian, V; Ramoz, N | 1 |
| Barabash, A; Cabranes, JA; De Juan, R; De Ugarte, C; Encinas, M; Fernández, C; Gil, P; Marcos, A | 1 |
| Guo, Y; Han, H; Li, H; Li, T; Liu, X; Ma, C; Shi, J; Tang, M; Wang, Y; Zhang, S; Zhao, J | 1 |
| Bernardi, G; Kawarai, T; Orlacchio, A; Paterson, AD; Polidoro, M; Rogaeva, E; St George-Hyslop, PH | 1 |
| Agosti, C; Akkawi, N; Archetti, S; Borroni, B; Brambilla, C; Caimi, L; Caltagirone, C; Di Luca, M; Padovani, A | 1 |
| Carson, R; Craig, D; Hart, DJ; McIlroy, SP; Passmore, AP | 1 |
| Green, R; Luchsinger, JA; Mayeux, R; Miller, J; Shea, S; Tang, MX | 1 |
| Bicíková, M; Hampl, R; Havlíková, H; Hill, M; Jirák, R; Rípová, D; Tallová, J | 1 |
| Brust, J; Jonas, S; Locko, R; McCurtis, H; Millman, E; Singh, D; Tikofsky, R; Van Heertum, R | 1 |
| Corder, EH; Helisalmi, S; Hiltunen, M; Iivonen, S; Koivisto, AM; Lehtovirta, M; Mannermaa, A; Soininen, H; Vepsäläinen, S | 1 |
| Benoit, M; Clairet, S; Darcourt, J; Koulibaly, PM; Robert, PH | 1 |
| Chang, GG; Chou, CY; Huang, YC; Lin, TH; Lin, YL; Sheu, SY; Shiao, MS; Tsay, HJ | 1 |
| Friede, T; Kieser, M; Röhmel, J | 1 |
| Pulliam, L; Rempel, HC | 1 |
| Kaji, R; Kawakami, H; Kuno, S; Nishimura, M | 1 |
| Cumming, RC; Schubert, D | 1 |
| Kodama, C; Matsuda, H; Nakano, S; Yamada, T; Yamashita, F | 1 |
| Kawarabayashi, T; Shoji, M | 1 |
| Anchisi, D; Borroni, B; Di Luca, M; Garibotto, V; Giubbini, R; Kerrouche, N; Padovani, A; Paghera, B; Perani, D; Terzi, A; Vicini, B; Vignolo, LA | 1 |
| Gu, Z; Lipton, SA; Ma, Y; Masliah, E; Nakamura, T; Nomura, Y; Shi, ZQ; Uehara, T; Yao, D | 1 |
| Ariga, H; Iguchi-Ariga, SM; Ooe, H | 1 |
| Chauhan, NB | 1 |
| Chotinaiwattarakul, W; Jamjumrus, P; Nako, A; Ratanamart, V; Senanarong, V; Siritho, S; Udompunthuruk, S | 1 |
| Benoit, M; Brugnolo, A; Darcourt, J; Girtler, N; Koulibaly, PM; Nobili, F; Robert, PH; Rodriguez, G | 1 |
| Butterfield, DA; Cai, J; Coccia, R; Klein, JB; Newman, SF; Perluigi, M; Pierce, WM; Sultana, R; Turner, DM | 1 |
| Hudson, PR; McCaddon, A | 1 |
| Chojnacka, K; Dorszewska, J; Florczak, J; Jaroszewska-Kolecka, J; Kempisty, B; Kozubski, W; Rozycka, A; Trzeciak, WH | 1 |
| Gupta, VB; Rao, KS | 1 |
| Altrinetti, V; Brugnolo, A; Koulibaly, PM; Mignone, A; Morbelli, S; Nobili, F; Piccardo, A; Pupi, A; Rodriguez, G | 1 |
| De la Fuente, M; Frank, A; Hernanz, A; Navarro, M | 1 |
| Araki, N; Imabayashi, E; Kuji, I; Matsuda, H; Ohkubo, T; Shimazu, K | 1 |
| Kawasaki, Y | 1 |
| Blanchard, BJ; Buchwald, SL; Deniz, AA; Duennwald, ML; Griffin, D; Hennessy, EJ; Ingram, VM; King, J; Krishnan, R; Lindquist, S; Mukhopadhyay, S; Roberts, BE; Rozeboom, LM; Shorter, J; Steele, AD; Su, LJ; Wang, H; Weigele, P; Zhang, YL | 1 |
| Hallikainen, M; Helkala, EL; Kuikka, J; Riekkinen, P; Soininen, H | 1 |
| Biernat, J; Mandelkow, E; Mandelkow, EM; Schweers, O | 1 |
| Bacciottini, L; Castagnoli, A; De Cristofaro, MT; Petti, AR; Pupi, A | 1 |
| Greenberg, JH; Lassen, NA | 1 |
| Andersen, AR; Bigelow, R; Hasselbalch, SG; Joseph, JL; Lassen, NA; Paulson, OB; Waldemar, G; Walovitch, RC | 1 |
| Beher, D; Beyreuther, K; Hesse, L; Masters, CL; Multhaup, G; Ruppert, T; Schlicksupp, A | 1 |
| Bennett, A; Bronen, RA; Cellar, J; Delaney, RC; Hoffer, PB; Lin, CH; Narayan, M; Robinson, R; Smith, EO; van Dyck, CH; Wisniewski, G | 1 |
| Matsuda, H; Nakano, S; Uno, M | 1 |
| Berger, W; Decristoforo, C; Donnemiller, E; Heilmann, J; Moncayo, R; Poewe, W; Ransmayr, G; Wenning, GK | 1 |
| Getz, GS; LaDu, MJ; Lukens, JR; Reardon, CA | 1 |
| Bartenstein, P; Buch, K; Hirsch, C; Kurz, A; Minoshima, S; Mösch, D; Schad, D; Schwaiger, M; Willoch, F | 1 |
| Helkala, EL; Kuikka, J; Laakso, M; Partanen, J; Riekkinen, M; Riekkinen, P; Soininen, H | 1 |
| Ashford, W; Davis, DG; Magoun, S; Shih, WJ; Stipp, V | 1 |
| Kawakatsu, S; Komatani, A; Sugai, Y; Watanabe, N; Yamaguchi, K | 1 |
| Davies, P; Friedhoff, P; Mandelkow, E; Mandelkow, EM; von Bergen, M | 1 |
| Ballinger, JR; Ichise, M; Ivo, BD; Vines, DC | 1 |
| Ishii, K; Kitagaki, H; Mori, E; Sakamoto, S; Sasaki, M; Yamaji, S | 1 |
| Aleem, A; Ashford, JW; Cool, C; Coupal, J; Kiefer, VH; Mendiondo, MS; Schmitt, FA; Schneider, A; Shetty, R; Shih, WJ | 1 |
| Bahia, VS; Buchpiguel, CA; Caixeta, L; Caramelli, P; Degenszajn, J; Mathias, SC; Nascimento, CM; Nitrini, R | 1 |
| Hoyer, S; Yun, SW | 1 |
| Berry, RW; Binder, LI; Gamblin, TC; King, ME; Kuret, J | 1 |
| Bhattacharya, K; Evans, DB; Rank, KB; Sharma, SK | 1 |
| Bayer, TA; Beher, D; Beyreuther, K; Hambsch, B; Hesse, L; Multhaup, G; Scheuermann, S; Schmidt, C; Stumm, J | 1 |
| Bentley, NM; Getz, GS; Ladu, MJ; Rajan, C; Reardon, CA | 1 |
| Arima, K; Asada, T; Eto, K; Kimura, H; Makifuchi, T | 1 |
| Altman, RA; Gonzalez-DeWhitt, PA; Greenberg, BD; Kisilevsky, R; Lowery, DE; Narindrasorasak, S | 1 |
| Avila, J; Correas, I; López-Otín, C; Nieto, A | 1 |
| Fearn, S; Heafield, MT; Steventon, GB; Sturman, SG; Waring, RH; Williams, AC | 1 |
11 review(s) available for cysteine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Towards development of disease-modifying therapy for Alzheimer's disease using redox chemical biology pathways.
Topics: Alzheimer Disease; Animals; Antioxidants; Biology; Cysteine; Kelch-Like ECH-Associated Protein 1; Mice; N-Methylaspartate; NF-E2-Related Factor 2; Oxidation-Reduction | 2022 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Glutathione-Mediated Neuroprotective Effect of Purine Derivatives.
Topics: Adenosine A2 Receptor Antagonists; Alzheimer Disease; Brain; Caffeine; Cysteine; Excitatory Amino Acid Transporter 3; Glutathione; Humans; Neuroprotection; Neuroprotective Agents; Parkinson Disease; Purines; Receptor, Adenosine A2A; Theophylline; Uric Acid | 2023 |
Ferroptosis: mechanisms and links with diseases.
Topics: Alzheimer Disease; Apoptosis; Autophagy; Cysteine; Ferroptosis; Humans; Iron; Lipid Metabolism; Lipid Peroxidation; Neoplasms; Parkinson Disease; Reactive Oxygen Species | 2021 |
A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cysteine; Humans; Leukotrienes; Molecular Targeted Therapy; Signal Transduction | 2019 |
Antioxidant enzymes as redox-based biomarkers: a brief review.
Topics: Aging; Alzheimer Disease; Animals; Antioxidants; Biomarkers; Catalysis; Cell Line, Tumor; Cysteine; Enzymes; Glutathione; Hep G2 Cells; Humans; Hypertension, Renal; Neurodegenerative Diseases; Oxidation-Reduction; Oxidative Stress; Oxygen; Peroxiredoxins; Protein Processing, Post-Translational; Proteomics; Reactive Oxygen Species; Reperfusion Injury | 2015 |
Lack of association between MTHFR A1298C variant and Alzheimer's disease: evidence from a systematic review and cumulative meta-analysis.
Topics: Alanine; Alzheimer Disease; Cysteine; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Single Nucleotide | 2017 |
Proteomic approaches to oxidative protein modifications implicated in the mechanism of aging.
Topics: Aging; Alzheimer Disease; Animals; Cysteine; Electrophoresis, Gel, Two-Dimensional; Humans; Isoelectric Focusing; Methionine; Oxidative Stress; Protein Biosynthesis; Protein Carbonylation; Proteomics; Reactive Oxygen Species | 2010 |
The "aged garlic extract:" (AGE) and one of its active ingredients S-allyl-L-cysteine (SAC) as potential preventive and therapeutic agents for Alzheimer's disease (AD).
Topics: Alzheimer Disease; Cysteine; Garlic; Humans; Inflammation; Nerve Degeneration; Plant Extracts | 2011 |
Emerging role of protein-protein transnitrosylation in cell signaling pathways.
Topics: Alzheimer Disease; Animals; Cell Death; Cysteine; Erythrocytes; Humans; Nitric Oxide; Nitrosation; Oxidation-Reduction; Protein Processing, Post-Translational; Proteins; S-Nitrosothiols; Signal Transduction | 2013 |
[Biomarker and imaging of Alzheimer's disease].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Biomarkers; Brain; Brain Chemistry; Cysteine; Enzyme-Linked Immunosorbent Assay; Humans; Magnetic Resonance Imaging; Organotechnetium Compounds; Plaque, Amyloid; Radiopharmaceuticals; tau Proteins; Tomography, Emission-Computed, Single-Photon | 2005 |
12 trial(s) available for cysteine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Diagnosis, Computer-Assisted; Disease Progression; Female; Humans; Linear Models; Longitudinal Studies; Male; Neuropsychological Tests; Organotechnetium Compounds; Perfusion; Tomography, Emission-Computed, Single-Photon | 2011 |
Brain SPET abnormalities in Alzheimer's disease before and after atrophy correction.
Topics: Aged; Alzheimer Disease; Artifacts; Atrophy; Brain; Cerebrovascular Circulation; Cysteine; Female; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Organotechnetium Compounds; Quality Control; Radiopharmaceuticals; Subtraction Technique; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2002 |
Combination of serum markers related to several mechanisms in Alzheimer's disease.
Topics: Adult; Aged; Aged, 80 and over; Aging; alpha 1-Antichymotrypsin; Alzheimer Disease; Analysis of Variance; Biomarkers; Chi-Square Distribution; Cholesterol; Cysteine; Female; Follow-Up Studies; Humans; Hydroxycholesterols; Interleukin-6; Logistic Models; Male; Middle Aged; Neurodegenerative Diseases; Parkinson Disease; Reference Values; Serum; Sterols | 2003 |
Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Disease Progression; Female; Humans; Longitudinal Ligaments; Male; Organotechnetium Compounds; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Statistics as Topic; Tomography, Emission-Computed, Single-Photon | 2003 |
rCBF/SPECT in the evaluation of inner-city minority patients with a history of impaired memory: a pilot blind read pre- and poststudy.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cysteine; Diagnosis, Differential; Diagnostic Errors; Educational Status; Female; Geriatric Assessment; Humans; Male; Memory Disorders; Minority Groups; Neuropsychological Tests; Organotechnetium Compounds; Pilot Projects; Regional Blood Flow; Single-Blind Method; Socioeconomic Factors; Tomography, Emission-Computed, Single-Photon; Urban Population | 2002 |
Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.
Topics: Alzheimer Disease; Cognition Disorders; Cysteine; Humans; Image Interpretation, Computer-Assisted; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Organotechnetium Compounds; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon | 2006 |
Tetrahydroaminoacridine modulates technetium-99m labelled ethylene dicysteinate retention in Alzheimer's disease measured with single photon emission computed tomography imaging.
Topics: Aged; Alzheimer Disease; Brain; Cerebellum; Cholinesterase Inhibitors; Cysteine; Double-Blind Method; Female; Humans; Male; Nootropic Agents; Organotechnetium Compounds; Tacrine; Tomography, Emission-Computed, Single-Photon | 1995 |
99mTc-bicisate (neurolite) SPECT brain imaging and cognitive impairment in dementia of the Alzheimer type: a blinded read of image sets from a multicenter SPECT trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognition Disorders; Cysteine; Female; Humans; Male; Mental Status Schedule; Middle Aged; Organotechnetium Compounds; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon | 1994 |
[Regional cerebral blood flow measurements using 99mTc-ECD SPECT in patients with Alzheimer's disease (ad) in the early stage].
Topics: Aged; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cysteine; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Regional Blood Flow; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 1996 |
Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amygdala; Apolipoprotein E4; Apolipoproteins E; Cerebrovascular Circulation; Cholinesterase Inhibitors; Cysteine; Female; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memory, Short-Term; Parasympathetic Nervous System; Plaque, Amyloid; Tacrine; Tomography, Emission-Computed, Single-Photon | 1998 |
SPECT in Alzheimer's disease: features associated with bilateral parietotemporal hypoperfusion.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Cysteine; Double-Blind Method; Female; Functional Laterality; Humans; Male; Middle Aged; Neuropsychological Tests; Organotechnetium Compounds; Parietal Lobe; Radiopharmaceuticals; Severity of Illness Index; Technetium Tc 99m Exametazime; Temporal Lobe; Tomography, Emission-Computed, Single-Photon | 2000 |
151 other study(ies) available for cysteine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Structure Optimization of the Toxic Conformation Model of Amyloid β42 by Intramolecular Disulfide Bond Formation.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Cysteine; Disulfides; Humans; Peptide Fragments | 2022 |
Mical modulates Tau toxicity via cysteine oxidation in vivo.
Topics: Alzheimer Disease; Animals; Cysteine; Cytoskeletal Proteins; DNA-Binding Proteins; Drosophila melanogaster; Humans; Microfilament Proteins; Mixed Function Oxygenases; Oxidation-Reduction; tau Proteins; Tauopathies | 2022 |
S-Nitrosylation of cathepsin B affects autophagic flux and accumulation of protein aggregates in neurodegenerative disorders.
Topics: Alzheimer Disease; Animals; Cathepsin B; Cysteine; Humans; Mice; Neurodegenerative Diseases; Nitric Oxide; Protein Aggregates; Proteins | 2022 |
Tau R2 and R3 are essential regions for tau aggregation, seeding and propagation.
Topics: Alzheimer Disease; Cysteine; HEK293 Cells; Heparin; Humans; tau Proteins; Tauopathies | 2022 |
Relative quantification of sulfenic acids in plasma proteins using differential labelling and mass spectrometry coupled with 473 nm photo-dissociation analysis: A multiplexed approach applied to an Alzheimer's disease cohort.
Topics: Alzheimer Disease; Blood Proteins; Cysteine; Humans; Maleimides; Mass Spectrometry; Neurodegenerative Diseases; Oxidation-Reduction; Peptides; Sulfenic Acids; Sulfhydryl Compounds | 2022 |
Role of the Cysteine in R3 Tau Peptide in Copper Binding and Reactivity.
Topics: Alanine; Alzheimer Disease; Copper; Cysteine; Disulfides; Dopamine; Humans; Peptides; Protein Aggregates; tau Proteins | 2022 |
New TEMPO-Appended 2,2'-Bipyridine-Based Eu(III), Tb(III), Gd(III) and Sm(III) Complexes: Synthesis, Photophysical Studies and Testing Photoluminescence-Based Bioimaging Abilities.
Topics: 2,2'-Dipyridyl; Alzheimer Disease; Animals; Cysteine; Fluorescence; Fluorescent Dyes; Glutathione; Ligands; Mice; Serum Albumin, Bovine; Sulfhydryl Compounds | 2022 |
Bifunctional cysteine gold nanoclusters for β-amyloid fibril inhibition and fluorescence imaging: a distinctive approach to manage Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Cysteine; Gold; Molecular Docking Simulation; Plaque, Amyloid; Sulfur | 2023 |
In silico exploration of antioxidants as oxidation protectant for PITRM1 peptidase activity, an Alzheimer disease target.
Topics: Alzheimer Disease; Antioxidants; Ascorbic Acid; Cysteine; Humans; Metalloendopeptidases; Molecular Docking Simulation; Molecular Dynamics Simulation; Peptide Hydrolases; Silymarin | 2023 |
Influence of N6-methyladenosine (m6A) modification on cell phenotype in Alzheimer's disease.
Topics: Adenosine; Alzheimer Disease; Cysteine; Databases, Protein; Endopeptidases; Humans; Phenotype | 2023 |
[Effect of aqueous extract of Corni Fructus on Aβ_(25-35)-induced brain injury and neuroinflammation in mice with Alzheimer's disease].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Aspartic Acid; Brain Injuries; Cornus; Cysteine; Disease Models, Animal; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molecular Docking Simulation; Neuroinflammatory Diseases; Peptide Hydrolases; Tumor Necrosis Factor-alpha | 2023 |
A diet rich in taurine, cysteine, folate, B
Topics: Alzheimer Disease; Animals; Betaine; Brain; Cysteine; Diet; Dietary Supplements; Folic Acid; Gases; Humans; Hydrogen Sulfide; Methylation; Risk; Taurine; Vitamin B 12 | 2019 |
N-Acetyl Cysteine and Catechin-Derived Polyphenols: A Path Toward Multi-Target Compounds Against Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Catechin; Cell Line, Tumor; Cysteine; Drug Discovery; Mice; Neurons; Polyphenols; tau Proteins | 2020 |
Labeling Antibodies.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antibodies; Biotin; Carbohydrates; Cross-Linking Reagents; Cysteine; Gold Colloid; Humans; Immunoconjugates; Isotope Labeling; Luminescent Proteins; Staining and Labeling; Sulfhydryl Compounds | 2020 |
Measuring Interactions Between Tau and Aggregation Inducers with Single-Molecule Förster Resonance Energy Transfer.
Topics: Alzheimer Disease; Calibration; Cell Line; Cloning, Molecular; Cysteine; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Humans; Intrinsically Disordered Proteins; Mutagenesis, Site-Directed; Organic Chemicals; Polyphosphates; Protein Aggregates; Protein Domains; Recombinant Proteins; Single Molecule Imaging; Spectrometry, Fluorescence; tau Proteins | 2020 |
Neurotherapeutic and antioxidant response of D-ribose-L-Cysteine nutritional dietary supplements on Alzheimer-type hippocampal neurodegeneration induced by cuprizone in adult male wistar rat model.
Topics: Alzheimer Disease; Animals; Antioxidants; Catalase; Cuprizone; Cysteine; Diet; Dietary Supplements; Food Contamination; Glutathione Synthase; Hippocampus; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Thiazolidines | 2021 |
Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cyclin-Dependent Kinase 5; Cysteine; Disease Models, Animal; Dynamins; HEK293 Cells; Humans; Mice; Mice, Transgenic; Mutation; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Oxidation-Reduction; Protein Processing, Post-Translational; Synapses; Ubiquitin Thiolesterase | 2021 |
Fluorescence switch of gold nanoclusters stabilized with bovine serum albumin for efficient and sensitive detection of cysteine and copper ion in mice with Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Copper; Cysteine; Fluorescence; Gold; Metal Nanoparticles; Mice; Serum Albumin, Bovine; Spectrometry, Fluorescence | 2021 |
Role of cysteines in accelerating Tau filament formation.
Topics: Alzheimer Disease; Cysteine; Humans; Microscopy, Electron, Transmission; Neurofibrillary Tangles; tau Proteins | 2022 |
Single Point Mutation from E22-to-K in A
Topics: Age of Onset; Aged; Alzheimer Disease; Animals; Catalase; China; Cysteine; Family Health; Female; Hippocampus; Humans; Hydrogen Peroxide; Male; Maze Learning; Middle Aged; Mutation; Neurons; Pedigree; Peptides; Phenotype; Point Mutation; Protein Binding; Rats; Rats, Sprague-Dawley | 2020 |
Metabolites Associated with Early Cognitive Changes Implicated in Alzheimer's Disease.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Cysteine; Disease Progression; Executive Function; Fatty Acids; Female; Humans; Longitudinal Studies; Male; Mendelian Randomization Analysis; Mental Recall; Metabolic Networks and Pathways; Metabolomics; Middle Aged; Prospective Studies | 2021 |
Segmental structural dynamics in Aβ42 globulomers.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cysteine; Electron Spin Resonance Spectroscopy; Humans; Models, Molecular; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Peptide Fragments; Protein Aggregates; Protein Aggregation, Pathological; Protein Conformation; Protein Multimerization; Protein Stability; Spin Labels | 2021 |
Changes in Biothiol Levels Are Closely Associated with Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Biomarkers; Brain; Cysteine; Down-Regulation; Early Diagnosis; Female; Fluorescent Dyes; Glutathione; Homocysteine; Humans; Male; Mice; Middle Aged; PC12 Cells; Rats; Spectrometry, Fluorescence; Sulfhydryl Compounds; Up-Regulation; Vitamin B 6; Vitamin B Complex | 2021 |
Detection of Alzheimer's disease using ECD SPECT images by transfer learning from FDG PET.
Topics: Alzheimer Disease; Brain; Cysteine; Fluorodeoxyglucose F18; Humans; Male; Organotechnetium Compounds; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon | 2021 |
Direct Quantification and Visualization of Homocysteine, Cysteine, and Glutathione in Alzheimer's and Parkinson's Disease Model Tissues.
Topics: Alzheimer Disease; Animals; Cysteine; Fluorescent Dyes; Glutathione; HeLa Cells; Homocysteine; Humans; Mice; Parkinson Disease | 2021 |
The intrinsic amyloidogenic propensity of cofilin-1 is aggravated by Cys-80 oxidation: A possible link with neurodegenerative diseases.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid; Amyloidogenic Proteins; Cofilin 1; Computer Simulation; Cysteine; Humans; Models, Molecular; Mutation; Neurodegenerative Diseases; Oxidation-Reduction; Propensity Score; Protein Aggregation, Pathological; Protein Stability; Protein Unfolding; Sequence Homology, Amino Acid | 2021 |
Effects of white matter lesions on brain perfusion in patients with mild cognitive impairment.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Cerebrovascular Circulation; Cognition; Cognitive Dysfunction; Cysteine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Organotechnetium Compounds; Perfusion; Tomography, Emission-Computed, Single-Photon; White Matter | 2018 |
Characteristic deterioration of ADAS-Jcog subscale scores and correlations with regional cerebral blood flow reductions in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cognition; Cysteine; Disease Progression; Donepezil; Female; Humans; Indans; Language; Male; Memory; Mental Status and Dementia Tests; Middle Aged; Nootropic Agents; Organotechnetium Compounds; Piperidines; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2018 |
Blocking the Thiol at Cysteine-322 Destabilizes Tau Protein and Prevents Its Oligomer Formation.
Topics: Alzheimer Disease; Animals; Apoptosis; Brain; Cysteine; Escherichia coli; HEK293 Cells; Humans; Hydrogen Peroxide; Mice, Transgenic; Protein Aggregation, Pathological; Protein Stability; Recombinant Proteins; Selenoprotein W; Sulfhydryl Compounds; tau Proteins | 2018 |
Preparation of Tau Oligomers After the Protein Extraction from Bacteria and Brain Cortices.
Topics: Alzheimer Disease; Animals; Autopsy; Bacteria; Brain; Chromatography, Affinity; Chromatography, High Pressure Liquid; Cysteine; Humans; Mice; Oxidation-Reduction; Protein Multimerization; Recombinant Proteins; tau Proteins | 2018 |
Cysteine-Independent Inhibition of Alzheimer's Disease-like Paired Helical Filament Assembly by Leuco-Methylthioninium (LMT).
Topics: Alzheimer Disease; Cysteine; Heparin; Humans; Methylene Blue; Molecular Structure; Neurofibrillary Tangles; Recombinant Proteins; Spectrum Analysis; tau Proteins | 2018 |
In Silico Identification of Novel Apolipoprotein E4 Inhibitor for Alzheimer's Disease Therapy.
Topics: Alzheimer Disease; Apolipoprotein E4; Benzopyrans; Biological Products; Catechin; Computer Simulation; Cysteine; Humans; Molecular Docking Simulation; Protein Interaction Domains and Motifs | 2019 |
Reversibility of Age-related Oxidized Free NADH Redox States in Alzheimer's Disease Neurons by Imposed External Cys/CySS Redox Shifts.
Topics: Aging; Alzheimer Disease; Animals; Cell Nucleus; Cells, Cultured; Cellular Senescence; Cysteine; Cystine; Cytoplasm; Disease Models, Animal; Energy Metabolism; Female; Hippocampus; Humans; Intravital Microscopy; Male; Mice; Mice, Transgenic; Microscopy, Fluorescence; Mitochondria; NAD; Neurons; Oxidation-Reduction; Oxidative Stress; Primary Cell Culture | 2019 |
Aminothienopyridazines and methylene blue affect Tau fibrillization via cysteine oxidation.
Topics: Alzheimer Disease; Cysteine; Humans; Methylene Blue; Multiprotein Complexes; Oxidation-Reduction; tau Proteins | 2013 |
Interaction of cinnamaldehyde and epicatechin with tau: implications of beneficial effects in modulating Alzheimer's disease pathogenesis.
Topics: Acrolein; Alzheimer Disease; Animals; Catechin; Cattle; Cysteine; In Vitro Techniques; Microscopy, Electron, Transmission; Microtubules; Oxidation-Reduction; Spectrometry, Mass, Electrospray Ionization; tau Proteins; Tubulin | 2013 |
Soluble oligomers of amyloid-β cause changes in redox state, DNA methylation, and gene transcription by inhibiting EAAT3 mediated cysteine uptake.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cells, Cultured; Cysteine; DNA Methylation; Epigenesis, Genetic; Excitatory Amino Acid Transporter 3; Gene Expression Regulation; Humans; Insulin-Like Growth Factor I; Neurons; Oxidation-Reduction; Oxidative Stress | 2013 |
Trail making test B and brain perfusion imaging in mild cognitive impairment and mild Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Female; Humans; Male; Organotechnetium Compounds; Perfusion Imaging; Psychiatric Status Rating Scales; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Trail Making Test | 2013 |
Modulation of human mitochondrial voltage-dependent anion channel 2 (hVDAC-2) structural stability by cysteine-assisted barrel-lipid interactions.
Topics: Alzheimer Disease; Cysteine; Humans; Mutation; Phosphorylcholine; Protein Folding; Protein Stability; Protein Structure, Tertiary; Voltage-Dependent Anion Channel 2 | 2013 |
Cysteine-rich domain of scavenger receptor AI modulates the efficacy of surface targeting and mediates oligomeric Aβ internalization.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Chlorocebus aethiops; COS Cells; Cysteine; Cytoplasm; Endoplasmic Reticulum; Humans; Lipoproteins, LDL; Protein Folding; Protein Structure, Tertiary; Proteolysis; Scavenger Receptors, Class A; Surface Properties | 2013 |
Presenilins regulate the cellular activity of ryanodine receptors differentially through isotype-specific N-terminal cysteines.
Topics: Alzheimer Disease; Amino Acid Sequence; Calcium; Calcium Signaling; Cell Line; Cysteine; Endoplasmic Reticulum; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Neurons; Peptides; Presenilins; Ryanodine Receptor Calcium Release Channel | 2013 |
Differential S-nitrosylation of proteins in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Biotin; Brain; Case-Control Studies; Cysteine; Electrophoresis, Gel, Two-Dimensional; Female; Fructose-Bisphosphate Aldolase; Humans; Male; Proteomics; S-Nitrosothiols; Superoxide Dismutase; Tandem Mass Spectrometry; Voltage-Dependent Anion Channel 2 | 2014 |
Depressive symptoms and regional cerebral blood flow in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Caregivers; Cerebral Cortex; Cerebrovascular Circulation; Cysteine; Depression; Depressive Disorder; Female; Frontal Lobe; Humans; Male; Middle Aged; Neuropsychological Tests; Organotechnetium Compounds; Psychiatric Status Rating Scales; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2014 |
Subjective depressive mood and regional cerebral blood flow in mild Alzheimer's disease.
Topics: Affect; Aged; Aged, 80 and over; Alzheimer Disease; Cerebrovascular Circulation; Cysteine; Data Interpretation, Statistical; Depression; Female; Frontal Lobe; Geriatric Assessment; Humans; Male; Organotechnetium Compounds; Psychiatric Status Rating Scales; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon | 2014 |
Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognition Disorders; Cysteine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Observer Variation; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2014 |
External cys/cySS redox state modification controls the intracellular redox state and neurodegeneration via Akt in aging and Alzheimer's disease mouse model neurons.
Topics: Aging; Alzheimer Disease; Animals; Cell Death; Cells, Cultured; Cysteine; Cystine; Disease Models, Animal; Extracellular Space; Glutathione; Male; Mice; Mice, Transgenic; NADP; Neurons; Oxidation-Reduction; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species | 2014 |
Inhibitor of the tyrosine phosphatase STEP reverses cognitive deficits in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amino Acid Sequence; Animals; Benzothiepins; Catalytic Domain; Cell Death; Cerebral Cortex; Cognition Disorders; Cysteine; Disease Models, Animal; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Male; Mice, Inbred C57BL; Mice, Knockout; Molecular Sequence Data; Neurons; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatases, Non-Receptor; Substrate Specificity | 2014 |
Sample multiplexing with cysteine-selective approaches: cysDML and cPILOT.
Topics: Alzheimer Disease; Animals; Cysteine; Isotope Labeling; Liver; Male; Mass Spectrometry; Mice; Mice, Transgenic; Peptide Fragments; Proteome; Proteomics; Sequence Analysis, Protein | 2015 |
Analysis of cerebral lobar microbleeds and a decreased cerebral blood flow in a memory clinic setting.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Female; Frontal Lobe; Humans; Intracranial Hemorrhages; Japan; Magnetic Resonance Imaging; Male; Organotechnetium Compounds; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon | 2015 |
Copper(II) complexation of tacrine hybrids with potential anti-neurodegenerative roles.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Chelating Agents; Cholinesterase Inhibitors; Coordination Complexes; Copper; Cysteine; Humans; Hydrogen-Ion Concentration; Models, Molecular; Molecular Structure; Spectrometry, Mass, Electrospray Ionization; Tacrine | 2015 |
New Tacrine Hybrids with Natural-Based Cysteine Derivatives as Multitargeted Drugs for Potential Treatment of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Blood-Brain Barrier; Cell Line, Tumor; Cholinesterase Inhibitors; Cysteine; Humans; Tacrine | 2016 |
Homodimerization Protects the Amyloid Precursor Protein C99 Fragment from Cleavage by γ-Secretase.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Cysteine; Humans; Protein Multimerization | 2015 |
S-allyl-L-cysteine and isoliquiritigenin improve mitochondrial function in cellular models of oxidative and nitrosative stress.
Topics: Aging; Alzheimer Disease; Animals; Chalcones; Cysteine; Humans; Mitochondria; Oxidation-Reduction; Oxidative Stress; Rats | 2016 |
A Single Biosensor for Evaluating the Levels of Copper Ion and L-Cysteine in a Live Rat Brain with Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Biosensing Techniques; Brain Chemistry; Copper; Cysteine; Electrochemical Techniques; Molecular Structure; Particle Size; Rats; Surface Properties | 2015 |
Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groups.
Topics: Adrenergic beta-Agonists; Alzheimer Disease; Animals; Behavior, Animal; Blotting, Western; Brain; Catechols; Cell Line, Tumor; Cysteine; Disease Models, Animal; Disease Progression; Drug Evaluation, Preclinical; Isoproterenol; Mice; Mice, Transgenic; Neurofibrillary Tangles; Neurons; Polymerization; tau Proteins | 2015 |
A simple isotopic labeling method to study cysteine oxidation in Alzheimer's disease: oxidized cysteine-selective dimethylation (OxcysDML).
Topics: Alzheimer Disease; Animals; Chromatography, Liquid; Cysteine; Humans; Isotope Labeling; Methylation; Mice; Mice, Transgenic; Oxidation-Reduction; Tandem Mass Spectrometry | 2016 |
Aβ-affected pathogenic induction of S-nitrosylation of OGT and identification of Cys-NO linkage triplet.
Topics: Acylation; Alzheimer Disease; Amyloid beta-Peptides; Calcium; Cell Line; Cysteine; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; N-Acetylglucosaminyltransferases; Nitric Oxide; Phosphorylation; Protein Processing, Post-Translational; Reactive Oxygen Species; Signal Transduction | 2016 |
High-throughput endogenous measurement of S-nitrosylation in Alzheimer's disease using oxidized cysteine-selective cPILOT.
Topics: Alzheimer Disease; Animals; Cysteine; Isotope Labeling; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oxidation-Reduction; Proteomics | 2016 |
Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow Cells; Cell Death; Chloride Channels; Cysteine; Female; Flufenamic Acid; Genotype; Inflammasomes; Inflammation; Interleukin-1beta; Macrophages; Mefenamic Acid; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; NLR Family, Pyrin Domain-Containing 3 Protein; Pattern Recognition, Visual; Rats | 2016 |
Positive affect and regional cerebral blood flow in Alzheimer's disease.
Topics: Affect; Aged; Aged, 80 and over; Alzheimer Disease; Apathy; Brain; Cerebrovascular Circulation; Cysteine; Depression; Female; Frontal Lobe; Humans; Male; Middle Aged; Organotechnetium Compounds; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Tomography, Emission-Computed, Single-Photon | 2016 |
The relationship between depressive symptoms and prefrontal hypoperfusion demonstrated by eZIS in patients with DAT.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Mapping; Cerebrovascular Circulation; Cerebrovascular Disorders; Cysteine; Depressive Disorder; Female; Functional Laterality; Gyrus Cinguli; Humans; Male; Organotechnetium Compounds; Predictive Value of Tests; Prefrontal Cortex; Tomography, Emission-Computed, Single-Photon | 2008 |
Comparison of the usefulness of brain perfusion SPECT and MIBG myocardial scintigraphy for the diagnosis of dementia with Lewy bodies.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cysteine; Diagnosis, Differential; Female; Heart; Humans; Lewy Body Disease; Male; Occipital Lobe; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2008 |
Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Ascorbic Acid; Benzothiazoles; Blotting, Western; Brain; Cerebral Ventricles; Cysteine; Dietary Supplements; Female; Glutathione; Hippocampus; Humans; Immunohistochemistry; Male; Mice; Mice, Transgenic; Plaque, Amyloid; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes; tau Proteins; Thiazoles; Transcription Factors; Tumor Suppressor Protein p53 | 2009 |
Differentiation of early-stage Alzheimer's disease from other types of dementia using brain perfusion single photon emission computed tomography with easy Z-score imaging system analysis.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cysteine; Dementia; Dementia, Vascular; Diagnosis, Differential; Disease Progression; Female; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Middle Aged; Neuropsychological Tests; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2008 |
Amyloid beta peptides with an additional cysteine residue can enhance immunogenicity and reduce the amyloid beta burden in an Alzheimer's disease mouse model.
Topics: Adjuvants, Immunologic; Alzheimer Disease; Alzheimer Vaccines; Amino Acid Sequence; Amyloid beta-Peptides; Animals; Brain; Cysteine; Disease Models, Animal; Female; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Peptide Fragments; Vaccination | 2009 |
Conformational detection of prion protein with biarsenical labeling and FlAsH fluorescence.
Topics: Alzheimer Disease; Animals; Cysteine; Fluoresceins; Fluorescence; Huntington Disease; Luminescent Measurements; Mice; Neurodegenerative Diseases; Organometallic Compounds; Parkinson Disease; Prion Diseases; Protein Folding; Protein Structure, Secondary; PrPC Proteins; Recombinant Proteins | 2009 |
S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury.
Topics: Alzheimer Disease; Amino Acid Motifs; Amyloid beta-Peptides; Animals; Cell Line; Cell Line, Tumor; Cerebral Cortex; Cysteine; Dynamins; Female; GTP Phosphohydrolases; Humans; Male; Mice; Mice, Transgenic; Microtubule-Associated Proteins; Mitochondria; Mitochondrial Proteins; Models, Molecular; Mutation; Neurons; Nitric Oxide; Peptide Fragments; Protein Multimerization; Protein Structure, Tertiary; S-Nitrosothiols | 2009 |
Analysis of SPECT brain images for the diagnosis of Alzheimer's disease using moments and support vector machines.
Topics: Alzheimer Disease; Brain; Cysteine; Humans; Image Interpretation, Computer-Assisted; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2009 |
SVM-based computer-aided diagnosis of the Alzheimer's disease using t-test NMSE feature selection with feature correlation weighting.
Topics: Alzheimer Disease; Artificial Intelligence; Brain; Cysteine; Humans; Image Interpretation, Computer-Assisted; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2009 |
Low micromolar zinc accelerates the fibrillization of human tau via bridging of Cys-291 and Cys-322.
Topics: Alzheimer Disease; Cysteine; Disulfides; Humans; Microscopy, Atomic Force; Molecular Sequence Data; Neurofibrillary Tangles; Oxidation-Reduction; Peptide Fragments; Protein Binding; Protein Conformation; Protein Folding; Recombinant Proteins; tau Proteins; Thermodynamics; Zinc | 2009 |
Computer aided diagnosis system for the Alzheimer's disease based on partial least squares and random forest SPECT image classification.
Topics: Alzheimer Disease; Cysteine; Humans; Image Interpretation, Computer-Assisted; Least-Squares Analysis; Organotechnetium Compounds; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2010 |
A novel mutation in the predicted TMIII domain of the PSEN2 gene in an Italian pedigree with atypical Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Cognition Disorders; Cysteine; DNA Mutational Analysis; Female; Humans; Italy; Male; Middle Aged; Mutation; Neuropsychological Tests; Pedigree; Presenilin-2; Protein Structure, Tertiary; Serine | 2010 |
s-Ethyl cysteine and s-propyl cysteine alleviate beta-amyloid induced cytotoxicity in nerve growth factor differentiated PC12 cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Differentiation; Cell Survival; Cysteine; DNA Fragmentation; Humans; Membrane Potential, Mitochondrial; Nerve Growth Factor; Neurons; Neuroprotective Agents; PC12 Cells; Rats | 2010 |
S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease.
Topics: Aging; Alzheimer Disease; Biotin; Brain; Cell Line, Transformed; Cysteine; Dithiothreitol; Dynamins; GTP Phosphohydrolases; Humans; Microscopy, Electron, Transmission; Microtubule-Associated Proteins; Mitochondrial Diseases; Mitochondrial Proteins; Postmortem Changes; Protein Multimerization | 2010 |
[Neuroimaging in Alzheimer's disease: findings in plasmapheresis with albumin].
Topics: Albumins; Alzheimer Disease; Brain; Brain Mapping; Clinical Trials as Topic; Cysteine; Double-Blind Method; Humans; Magnetic Resonance Imaging; Organotechnetium Compounds; Plasmapheresis; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2010 |
Optimized data preprocessing for multivariate analysis applied to 99mTc-ECD SPECT data sets of Alzheimer's patients and asymptomatic controls.
Topics: Aged; Aged, 80 and over; Algorithms; Alzheimer Disease; Cysteine; Data Interpretation, Statistical; Discriminant Analysis; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multivariate Analysis; Organotechnetium Compounds; Principal Component Analysis; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon | 2011 |
S-propargyl-cysteine (ZYZ-802), a sulphur-containing amino acid, attenuates beta-amyloid-induced cognitive deficits and pro-inflammatory response: involvement of ERK1/2 and NF-κB pathway in rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cognition; Cysteine; Humans; Male; Neurons; Rats; Rats, Sprague-Dawley | 2011 |
Oxidative insults to neurons and synapse are prevented by aged garlic extract and S-allyl-L-cysteine treatment in the neuronal culture and APP-Tg mouse model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Cell Line, Transformed; Cysteine; Disease Models, Animal; Exploratory Behavior; Garlic; Gene Expression Regulation; Humans; Hydrogen Peroxide; L-Lactate Dehydrogenase; Memory, Short-Term; Mice; Mice, Transgenic; Neurons; Neuroprostanes; Plant Extracts; Rats; Reactive Oxygen Species; Synapses; Synaptophysin; Synaptosomal-Associated Protein 25; Time Factors | 2011 |
Astrocytic redox remodeling by amyloid beta peptide.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Astrocytes; Cells, Cultured; Cystathionine beta-Synthase; Cysteine; Cystine; DNA; Dose-Response Relationship, Drug; Homeostasis; Humans; Mice; Mice, Inbred BALB C; Neurons; Oxidation-Reduction; Reactive Oxygen Species; tert-Butylhydroperoxide | 2011 |
Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
Topics: Algorithms; Aluminum; Alzheimer Disease; Amyloid beta-Peptides; Computer Simulation; Copper; Cysteine; Humans; Insulysin; Sequence Homology, Amino Acid; Silver; Zinc | 2011 |
S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type.
Topics: Alzheimer Disease; Animals; Antioxidants; Apoptosis; Cysteine; Disease Models, Animal; Immunohistochemistry; Injections, Intraventricular; Maze Learning; Mice; Nerve Degeneration; Neurotoxins; Oxidative Stress; Streptozocin | 2011 |
s-Allyl cysteine, s-ethyl cysteine, and s-propyl cysteine alleviate β-amyloid, glycative, and oxidative injury in brain of mice treated by D-galactose.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cysteine; Disease Models, Animal; Galactose; Glycosylation; Humans; Male; Mice; Mice, Inbred C57BL; Oxidative Stress | 2011 |
S-Glutathionyl quantification in the attomole range using glutaredoxin-3-catalyzed cysteine derivatization and capillary gel electrophoresis with laser-induced fluorescence detection.
Topics: Alzheimer Disease; Animals; Cattle; Cysteine; Disease Models, Animal; Electrophoresis, Capillary; Fluorescence; Glutaredoxins; Glutathione; HT29 Cells; Humans; Lasers; Mice; Oxidation-Reduction; Protein Processing, Post-Translational; Serum Albumin, Bovine | 2011 |
S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Brain; Cyclin-Dependent Kinase 5; Cysteine; Dendritic Spines; Dynamins; Enzyme Activation; HEK293 Cells; Humans; Mutation; N-Methylaspartate; Nitric Oxide; Nitrosation; Rats; Synapses | 2011 |
Key residues for the oligomerization of Aβ42 protein in Alzheimer's disease.
Topics: Alzheimer Disease; Amino Acid Substitution; Amyloid beta-Peptides; Chaperonin 10; Cysteine; Humans; Microscopy, Electron, Transmission; Mutagenesis; Peptide Fragments; Protein Denaturation; Recombinant Fusion Proteins; Ubiquitin; Urea | 2011 |
Probing structural features of Alzheimer's amyloid-β pores in bilayers using site-specific amino acid substitutions.
Topics: Alzheimer Disease; Amino Acid Substitution; Amyloid beta-Peptides; Crystallography, X-Ray; Cysteine; DNA Mutational Analysis; Humans; Hydrophobic and Hydrophilic Interactions; Lipid Bilayers; Models, Molecular; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Peptide Fragments; Phenylalanine; Point Mutation; Proline | 2012 |
Metabolite profiling of Alzheimer's disease cerebrospinal fluid.
Topics: Alzheimer Disease; Case-Control Studies; Cysteine; Disease Progression; Gas Chromatography-Mass Spectrometry; Humans; Hydrocortisone; Metabolome; Sensitivity and Specificity; Uridine | 2012 |
Has removal of excess cysteine led to the evolution of pheomelanin? Pheomelanogenesis as an excretory mechanism for cysteine.
Topics: Alzheimer Disease; Cysteine; Cysteine Dioxygenase; Diet; Evolution, Molecular; Glutathione; Humans; Melanins; Melanocytes; Oxidative Stress; Parkinson Disease; Selection, Genetic; Temperature; Ultraviolet Rays | 2012 |
Toxic role of K+ channel oxidation in mammalian brain.
Topics: 2,2'-Dipyridyl; Age Factors; Alanine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Animals, Genetically Modified; Apoptosis; Brain; Caenorhabditis elegans; Cells, Cultured; Cricetinae; Cricetulus; Cysteine; Disease Models, Animal; Disulfides; Electric Stimulation; Embryo, Mammalian; Female; Fluoresceins; Humans; Hydrogen Peroxide; Male; Mass Spectrometry; Membrane Potentials; Mice; Neurons; Oxidants; Oxidation-Reduction; Oxidative Stress; Patch-Clamp Techniques; Peptide Fragments; Presenilin-1; Propanols; Shab Potassium Channels; Transfection | 2012 |
Cerebral small vessel disease in aging and Alzheimer's disease: a comparative study using MRI and SPECT.
Topics: Aged; Aging; Alzheimer Disease; Brain; Cerebral Small Vessel Diseases; Cysteine; Female; Humans; Leukoaraiosis; Magnetic Resonance Imaging; Male; Nerve Fibers, Myelinated; Neuroimaging; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2013 |
Two-dimensional nitrosylated protein fingerprinting by using poly (methyl methacrylate) microchips.
Topics: Alzheimer Disease; Animals; Chromatography, Micellar Electrokinetic Capillary; Cysteine; Electrophoresis, Capillary; Electrophoresis, Gel, Two-Dimensional; HT29 Cells; Humans; Mice; Mice, Transgenic; Oxidative Stress; Peptide Mapping; Polymethyl Methacrylate; Protein Processing, Post-Translational; Proteins; Vitamin K 3 | 2012 |
Correlation between serum 25-hydroxyvitamin D concentrations and regional cerebral blood flow in degenerative dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebrovascular Circulation; Cysteine; Female; Humans; Lewy Body Disease; Male; Middle Aged; Multimodal Imaging; Organotechnetium Compounds; Positron-Emission Tomography; Regional Blood Flow; Tomography, X-Ray Computed; Vitamin D | 2012 |
Molecular engineering of a secreted, highly homogeneous, and neurotoxic aβ dimer.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cell Line; Computational Biology; Cysteine; Dimerization; Humans; Mutation; Transfection | 2011 |
Mechanistic basis of phenothiazine-driven inhibition of Tau aggregation.
Topics: Alzheimer Disease; Animals; Caenorhabditis elegans; Cysteine; Disease Models, Animal; Humans; Magnetic Resonance Spectroscopy; Methylene Blue; Oxidation-Reduction; Phenothiazines; Protein Binding; tau Proteins | 2013 |
Neuroprotective effect of garlic compounds in amyloid-beta peptide-induced apoptosis in vitro.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Caspase 3; Caspases; Cell Survival; Cysteine; DNA Fragmentation; Enzyme Activation; Garlic; Humans; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Peptide Fragments; Plant Extracts; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proteins; Rats; Reactive Oxygen Species | 2002 |
Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies.
Topics: Aged; Alzheimer Disease; Brain; Cysteine; Diagnosis, Differential; Feasibility Studies; Female; Hallucinations; Humans; Lewy Body Disease; Male; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2002 |
Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments.
Topics: Alzheimer Disease; Anions; Arachidonic Acid; Cross-Linking Reagents; Cysteine; Disulfides; Heparin; Humans; Mutagenesis, Site-Directed; Neurofibrillary Tangles; Polyelectrolytes; Polymers; Protein Isoforms; Protein Processing, Post-Translational; Spectrometry, Fluorescence; tau Proteins | 2002 |
Alzheimer's disease and total plasma aminothiols.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Chromatography, High Pressure Liquid; Cysteine; Folic Acid; Glutathione; Homocysteine; Humans; Mental Status Schedule; Neuropsychological Tests; Prognosis; Reference Values; Vitamin B 12 | 2003 |
99mTc-HMPAO and 99mTc-ECD perform differently in typically hypoperfused areas in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Ischemia; Case-Control Studies; Cysteine; Female; Humans; Male; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Exametazime | 2003 |
Lack of association between the interleukin-1alpha gene C(-889)T polymorphism and Alzheimer's disease in a Chinese population.
Topics: Aged; Aged, 80 and over; Alleles; Alzheimer Disease; Asian People; Cysteine; DNA Mutational Analysis; Female; Gene Frequency; Genotype; Humans; Interleukin-1; Male; Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Threonine | 2003 |
Lack of association between the levels of the low-density lipoprotein receptor-related protein (LRP) and either Alzheimer dementia or LRP exon 3 genotype.
Topics: Alzheimer Disease; Blotting, Western; Brain; Brain Chemistry; Cohort Studies; Cysteine; Exons; Genotype; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Low Density Lipoprotein Receptor-Related Protein-1; Polymorphism, Genetic; Threonine | 2003 |
Possible association between Cys311Ser polymorphism of paraoxonase 2 gene and late-onset Alzheimer's disease in Chinese.
Topics: Aged; Aged, 80 and over; Alleles; Alzheimer Disease; Apolipoproteins E; Aryldialkylphosphatase; Asian People; Chi-Square Distribution; Cysteine; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Polymerase Chain Reaction; Polymorphism, Genetic; Serine | 2004 |
Lack of association between Alzheimer's disease and the promoter region polymorphisms of the nicastrin gene.
Topics: Adult; Age of Onset; Aged; Alanine; Alleles; Alzheimer Disease; Amyloid Precursor Protein Secretases; Apolipoproteins E; Cysteine; Female; Gene Frequency; Glycine; Haplotypes; Humans; Logistic Models; Male; Membrane Glycoproteins; Middle Aged; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Threonine | 2004 |
Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Apolipoproteins E; Case-Control Studies; Chi-Square Distribution; Cholesterol 24-Hydroxylase; Cysteine; Female; Follow-Up Studies; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Introns; Male; Mental Status Schedule; Odds Ratio; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; RNA, Messenger; Steroid Hydroxylases; Time Factors; Tyrosine | 2004 |
Allelic variation at the A218C tryptophan hydroxylase polymorphism influences agitation and aggression in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Aggression; Alanine; Alzheimer Disease; Chi-Square Distribution; Cohort Studies; Cysteine; Female; Gene Frequency; Genetic Variation; Genotype; Humans; Linkage Disequilibrium; Male; Middle Aged; Polymorphism, Genetic; Psychiatric Status Rating Scales; Psychomotor Agitation; Retrospective Studies; Sex Factors; Tryptophan Hydroxylase | 2004 |
Plasma homocysteine levels and risk of Alzheimer disease.
Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Apolipoproteins E; Cohort Studies; Comorbidity; Confounding Factors, Epidemiologic; Cross-Sectional Studies; Cysteine; Dementia; Diabetes Mellitus; Ethnicity; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Male; Memory; Neuropsychological Tests; New York City; Prevalence; Risk Factors; Sampling Studies; Stroke; Vitamin B 12; Vitamin B 6 | 2004 |
Plasma levels of 7-hydroxylated dehydroepiandrosterone (DHEA) metabolites and selected amino-thiols as discriminatory tools of Alzheimer's disease and vascular dementia.
Topics: 17-alpha-Hydroxypregnenolone; Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Chromatography, High Pressure Liquid; Cysteine; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dementia, Vascular; Dipeptides; Female; Glutathione; Homocysteine; Humans; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Pregnenolone; Radioimmunoassay; Sensitivity and Specificity; Sex Factors; Statistics, Nonparametric; Sulfhydryl Compounds | 2004 |
Genetic variation in apolipoprotein D and Alzheimer's disease.
Topics: Age of Onset; Aged; Alanine; Alzheimer Disease; Apolipoproteins; Apolipoproteins D; Case-Control Studies; Cysteine; Female; Finland; Gene Frequency; Genetic Variation; Genotype; Glycine; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Threonine | 2004 |
Brain perfusion correlates of the apathy inventory dimensions of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Humans; Middle Aged; Mood Disorders; Motivation; Organotechnetium Compounds; Tomography, Emission-Computed, Single-Photon | 2004 |
Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution.
Topics: Alleles; Alzheimer Disease; Anilino Naphthalenesulfonates; Apolipoprotein E3; Apolipoproteins; Apolipoproteins A; Apolipoproteins E; Arginine; Arteriosclerosis; Biophysics; Brain; Buffers; Circular Dichroism; Cysteine; Electrophoresis, Polyacrylamide Gel; Genetic Vectors; Humans; Light; Microscopy, Fluorescence; Models, Molecular; Models, Statistical; Plasmids; Protein Conformation; Protein Isoforms; Protein Structure, Secondary; Protein Structure, Tertiary; Scattering, Radiation; Spectrometry, Fluorescence | 2005 |
Power and sample size determination when assessing the clinical relevance of trial results by 'responder analyses'.
Topics: Activities of Daily Living; Alzheimer Disease; Clinical Trials as Topic; Cognition; Cysteine; Drug Combinations; Humans; Pantothenic Acid; Risk Assessment; Sample Size; Treatment Outcome | 2004 |
HIV-1 Tat inhibits neprilysin and elevates amyloid beta.
Topics: Adult; Aging; AIDS Dementia Complex; Alzheimer Disease; Amyloid beta-Peptides; Brain; Cell Membrane; Cells, Cultured; Cysteine; Frontal Lobe; Gene Products, tat; HIV Infections; HIV-1; Humans; Immunohistochemistry; Middle Aged; Neprilysin; tat Gene Products, Human Immunodeficiency Virus | 2005 |
Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain-Derived Neurotrophic Factor; Cysteine; Female; Genetic Predisposition to Disease; Humans; Japan; Male; Methionine; Middle Aged; Multiple System Atrophy; Parkinson Disease; Polymorphism, Genetic; Threonine; Valine | 2005 |
Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Line; Cell Nucleus; Cysteine; Cytoplasm; Cytosol; Detergents; Digitonin; Disulfides; Dithiothreitol; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Female; Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating); Glycolysis; Humans; Hydrogen Peroxide; Immunoblotting; Male; Mice; Mice, Transgenic; Models, Biological; Neurodegenerative Diseases; Neurons; Oxidants; Oxidation-Reduction; Polymorphism, Genetic; Protein Isoforms; Rats; Reactive Oxygen Species; Risk; Time Factors | 2005 |
Relationship between delusions and regional cerebral blood flow in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Cysteine; Delusions; Humans; Organotechnetium Compounds; Reference Values; Regional Blood Flow; Tomography, Emission-Computed, Single-Photon | 2006 |
S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration.
Topics: Alzheimer Disease; Animals; Binding Sites; Cell Line; Cysteine; Endoplasmic Reticulum; Humans; Molecular Chaperones; N-Methylaspartate; Neurodegenerative Diseases; Nitric Oxide; Parkinson Disease; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Disulfide-Isomerases; Protein Folding; Receptors, G-Protein-Coupled; Sulfhydryl Compounds; Ubiquitin | 2006 |
Establishment of specific antibodies that recognize C106-oxidized DJ-1.
Topics: Alzheimer Disease; Antibody Specificity; Brain; Cysteine; Humans; Intracellular Signaling Peptides and Proteins; Oncogene Proteins; Parkinson Disease; Protein Deglycase DJ-1 | 2006 |
Effect of aged garlic extract on APP processing and tau phosphorylation in Alzheimer's transgenic model Tg2576.
Topics: Allyl Compounds; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Blotting, Western; Brain; Cysteine; Disease Models, Animal; Disulfides; Enzyme-Linked Immunosorbent Assay; Female; Garlic; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuroprotective Agents; Phosphorylation; Plant Extracts; Protein Processing, Post-Translational; tau Proteins | 2006 |
Patterns of single photon emission tomography (SPECT) among patients with dementia in the memory clinic at Siriraj Hospital.
Topics: Alzheimer Disease; Cerebrovascular Circulation; Cysteine; Dementia, Vascular; Diagnosis, Differential; Humans; Neuropsychological Tests; Organotechnetium Compounds; Radiopharmaceuticals; Retrospective Studies; Severity of Illness Index; Thailand; Tomography, Emission-Computed, Single-Photon | 2006 |
99mTc-HMPAO and 99mTc-ECD brain uptake correlates of verbal memory in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cysteine; Female; Humans; Male; Mental Recall; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon; Verbal Behavior | 2007 |
An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach.
Topics: Aged; Aged, 80 and over; alpha-Crystallin B Chain; Alzheimer Disease; Case-Control Studies; Cysteine; Female; Glutathione; Hemoglobins; Hippocampus; Humans; Male; Oxidation-Reduction; Oxidative Stress; Parietal Lobe; Phosphopyruvate Hydratase; Phosphoric Monoester Hydrolases; Proteomics | 2007 |
Methylation and phosphorylation: a tangled relationship?
Topics: Age Factors; Alzheimer Disease; Biomarkers; Cysteine; Folic Acid; Humans; Methylation; Phosphorylation; S-Adenosylhomocysteine; tau Proteins; Tauopathies | 2007 |
Oxidative DNA damage and level of thiols as related to polymorphisms of MTHFR, MTR, MTHFD1 in Alzheimer's and Parkinson's diseases.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Cysteine; Deoxyguanosine; DNA Damage; DNA Mutational Analysis; Female; Homocystine; Humans; Male; Methionine; Methylenetetrahydrofolate Dehydrogenase (NADP); Middle Aged; Parkinson Disease; Polymorphism, Genetic; Sulfhydryl Compounds; Tetrahydrofolates | 2007 |
Anti-amyloidogenic activity of S-allyl-L-cysteine and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Benzothiazoles; Cysteine; Humans; Macromolecular Substances; Microscopy, Electron, Transmission; Neuroprotective Agents; Protein Binding; Protein Conformation; Protein Folding; Thiazoles | 2007 |
The need of appropriate brain SPECT templates for SPM comparisons.
Topics: Adolescent; Adult; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Cysteine; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 2008 |
Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cognition Disorders; Cysteine; Down-Regulation; Female; Glutathione; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Receptors, Tumor Necrosis Factor, Type II; Sulfhydryl Compounds; Up-Regulation | 2007 |
Effect of nilvadipine on regional cerebral blood flow in a patient with early Alzheimer disease.
Topics: Aged, 80 and over; Alzheimer Disease; Antihypertensive Agents; Cerebrovascular Circulation; Cysteine; Female; Humans; Hypertension; Nifedipine; Organotechnetium Compounds; Radiopharmaceuticals; Regional Blood Flow; Tomography, Emission-Computed, Single-Photon | 2008 |
[Advance prediction of Mild Cognitive Impairment (MCI) using (99m)Tc-ECD SPECT brain blood flow imaging].
Topics: Alzheimer Disease; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Humans; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2008 |
Direct and selective elimination of specific prions and amyloids by 4,5-dianilinophthalimide and analogs.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Biological Transport; Biophysics; Cysteine; Fluorescence Resonance Energy Transfer; Humans; Models, Biological; Peptide Fragments; Peptide Termination Factors; Phthalimides; Prions; Protein Conformation; Protein Folding; Saccharomyces cerevisiae Proteins | 2008 |
Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments.
Topics: Alzheimer Disease; Benzothiazoles; Brain; Cysteine; Fluorescent Dyes; Humans; Neurofibrillary Tangles; Oxidation-Reduction; Phosphorylation; Protein Conformation; Sulfhydryl Reagents; tau Proteins; Thiazoles | 1995 |
Quantitative comparison between 99mTc-HMPAO and 99mTc-ECD: measurement of arterial input and brain retention.
Topics: Aged; Alzheimer Disease; Cerebrovascular Disorders; Cysteine; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Oximes; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1994 |
Characterization of 99mTc-bicisate as an agent for the measurement of cerebral blood flow with SPECT.
Topics: Alzheimer Disease; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Cysteine; Humans; Organotechnetium Compounds; Parkinson Disease; Tomography, Emission-Computed, Single-Photon | 1994 |
The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I)
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Binding Sites; Copper; Cysteine; Cystine; Electron Transport; Ferric Compounds; Histidine; Humans; Hydrogen Peroxide; Hydroxyl Radical; Mass Spectrometry; Oligopeptides; Oxidation-Reduction; Peptide Fragments; Recombinant Fusion Proteins; Superoxides | 1996 |
Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Analysis of Variance; Brain; Cysteine; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Oximes; ROC Curve; Sensitivity and Specificity; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1996 |
Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease.
Topics: Aged; Alzheimer Disease; Brain; Carrier Proteins; Case-Control Studies; Cocaine; Cysteine; Dementia; Diagnosis, Differential; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Organotechnetium Compounds; Oximes; Parkinson Disease; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1997 |
Association of human, rat, and rabbit apolipoprotein E with beta-amyloid.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apolipoprotein E2; Apolipoprotein E3; Apolipoproteins E; Cell Line; Cysteine; Disease Susceptibility; Genotype; Humans; Lipoproteins; Peptide Fragments; Protein Binding; Rabbits; Rats; Species Specificity; Transfection | 1997 |
Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT.
Topics: Alzheimer Disease; Cerebrovascular Circulation; Cognition; Cysteine; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 1997 |
Bilateral perfusion defect/hypoperfusion in temporal and parietal regions on brain SPECT.
Topics: Aged; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cysteine; Fatal Outcome; Humans; Male; Organotechnetium Compounds; Parietal Lobe; Radiopharmaceuticals; Temporal Lobe; Tomography, Emission-Computed, Single-Photon | 1998 |
[Discrepancy between 99mTc-HMPAO and 99mTc-ECD in Alzheimer's disease: does the retention mechanism depend on the disease?].
Topics: Alzheimer Disease; Brain; Cerebrovascular Circulation; Cysteine; Esterases; Glutathione; Humans; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Exametazime; Xenon Radioisotopes | 1998 |
A nucleated assembly mechanism of Alzheimer paired helical filaments.
Topics: Alzheimer Disease; Cysteine; Dimerization; Humans; Kinetics; Models, Chemical; Neurofibrillary Tangles; tau Proteins | 1998 |
External radioactive reference markers in SPECT imaging of the dopamine system.
Topics: Alzheimer Disease; Brain; Carrier Proteins; Case-Control Studies; Cocaine; Cysteine; Dopamine Plasma Membrane Transport Proteins; Humans; Iodine Radioisotopes; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Organotechnetium Compounds; Parkinson Disease; Radiopharmaceuticals; Receptors, Dopamine; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon | 1999 |
Tc-99m ethyl cysteinate dimer SPECT and 2-[F-18]fluoro-2-deoxy-D-glucose PET in Alzheimer's disease. Comparison of perfusion and metabolic patterns.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cysteine; Female; Fluorodeoxyglucose F18; Humans; Male; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
Single SPECT measures of cerebral cortical perfusion reflect time-index estimation of dementia severity in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cysteine; Female; Humans; Image Processing, Computer-Assisted; Male; Mental Status Schedule; Organotechnetium Compounds; Radiopharmaceuticals; Severity of Illness Index; Time Factors; Tomography, Emission-Computed, Single-Photon | 2000 |
Effects of low-level lead on glycolytic enzymes and pyruvate dehydrogenase of rat brain in vitro: relevance to sporadic Alzheimer's disease?
Topics: Adenosine Triphosphate; Alzheimer Disease; Animals; Brain; Chelating Agents; Cysteine; Dithiothreitol; Edetic Acid; Enzyme Activation; Glyceraldehyde-3-Phosphate Dehydrogenases; Glycolysis; Hexokinase; In Vitro Techniques; Lead; Male; Organometallic Compounds; Pyruvate Dehydrogenase Complex; Pyruvate Kinase; Rats; Rats, Wistar | 2000 |
Oxidative regulation of fatty acid-induced tau polymerization.
Topics: Actin Cytoskeleton; Alzheimer Disease; Antioxidants; Buffers; Butylated Hydroxytoluene; Cysteine; Dithiothreitol; Fatty Acids, Nonesterified; Humans; Microscopy, Electron; Mutagenesis, Site-Directed; Oxidation-Reduction; Oxidative Stress; Polymers; tau Proteins | 2000 |
Role of cysteine-291 and cysteine-322 in the polymerization of human tau into Alzheimer-like filaments.
Topics: Alzheimer Disease; Biopolymers; Cysteine; Dithiothreitol; Electrophoresis, Polyacrylamide Gel; Humans; Microscopy, Electron; Protein Isoforms; tau Proteins | 2001 |
Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Binding Sites; Blotting, Western; Cell Membrane; Chromatography, Gel; Collagen; COS Cells; Cross-Linking Reagents; Cysteine; Dimerization; Disulfides; Humans; Immunoblotting; Lysine; Mutagenesis, Site-Directed; Mutation; Protein Binding; Protein Structure, Tertiary; Recombinant Proteins; Signal Transduction; Transfection; Tumor Cells, Cultured | 2001 |
Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Apolipoproteins E; Arginine; Cysteine; DNA, Complementary; Humans; Macromolecular Substances; Mutagenesis, Site-Directed; Peptide Fragments; Protein Binding; Protein Isoforms; Protein Structure, Tertiary; Salts; Sodium Dodecyl Sulfate | 2002 |
Brain hydrogen sulfide is severely decreased in Alzheimer's disease.
Topics: Alzheimer Disease; Amino Acids; Blotting, Western; Brain; Cysteine; Dose-Response Relationship, Drug; Homocysteine; Humans; Hydrogen Sulfide; S-Adenosylmethionine | 2002 |
Characterization of high affinity binding between laminin and Alzheimer's disease amyloid precursor proteins.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Binding, Competitive; Cations, Divalent; Chlorides; Cysteine; Enzyme-Linked Immunosorbent Assay; Ethylmaleimide; Heparan Sulfate Proteoglycans; Heparitin Sulfate; Humans; Laminin; Proteoglycans; Zinc; Zinc Compounds; Zinc Fingers | 1992 |
Tau-related protein present in paired helical filaments has a decreased tubulin binding capacity as compared with microtubule-associated protein tau.
Topics: Alzheimer Disease; Amino Acid Sequence; Brain Chemistry; Cysteine; Humans; Molecular Sequence Data; Thiocyanates; Tubulin | 1991 |
Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Cysteine; Humans; Middle Aged; Motor Neurons; Neuromuscular Diseases; Parkinson Disease; Sulfates | 1990 |